GLP-1 agonists are a class of injectable medications that are used for type 2 diabetes and weight management. Some of the agents have also been shown to reduce the risk of major adverse cardiovascular events such as cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke. More recently, these agents have